Refine by
Implant Technology Articles & Analysis: Older
50 news found
In a ground-breaking advancement for cardiovascular care, Hiden Analytical Ltd is proud to announce a surface measurement technique for devices critical in the treatment of heart disease. Utilizing the most sensitive surface analysis technology, Secondary Ion Mass Spectrometry (SIMS), Hiden Analytical is setting new standards in the safety, efficacy, and innovation of stent technology. Surgical ...
When the number of elderly people occupies a large proportion of the total population of society, concern for the life and health of the elderly is a topic for the whole society. With the development of technology, modern medicine plays an important role in the diagnosis and treatment of common diseases in the elderly. In order to maintain the quality of life into old age, at the ...
Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBrace® Implant technology. The BioBrace Implant is an innovative bioinductive scaffold that is intended to reinforce soft tissue where weakness exists and facilitate healing. ...
Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBrace® Implant technology. The BioBrace implant is an innovative bioinductive scaffold that is intended to reinforce soft tissue where weakness exists and facilitate healing. ...
Mehendale served in leadership roles at Stryker, Zimmer-Biomet, and United Technologies. “We are excited that Park has joined our leadership ...
To see video, please click here About the Stentrode Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control digital devices through thought and improve functional independence. Synchron’s foundational technology, a motor neuroprosthesis (MNP), or motor BCI, is ...
About the Stentrode Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control digital devices through thought and improve functional independence. Synchron’s foundational technology, a motor neuroprosthesis (MNP), or motor BCI, is implanted via ...
This ‘community-first’ architecture will result in a successful user interface to serve not only the ALS population, but everyone who can benefit from emerging technologies like the Stentrode.” Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control ...
About the Stentrode Synchron’s flagship technology, the Stentrode, is an endovascular brain implant designed to enable patients to wirelessly control digital devices through thought and improve functional independence. Synchron’s foundational technology, a motor neuroprosthesis (MNP), is implanted via the jugular ...
Using a cell-seeded scaffold, which we call the Biostage Bronchial Implant, or BBI, we have performed the regeneration and repair of a bronchus (the airway that connects the trachea to the lungs) that was surgically removed from a pig. ...
Neuspera Medical, a medical device company developing implantable medical device technology for patients battling chronic illness, today announced the hiring of industry veterans Melissa Farina as Chief Financial Officer and Steven Siegel, MD, as Chief Medical Officer. ...
Synchron is the only company to receive FDA approval to conduct clinical trials of a permanently implanted BCI. The company’s novel BCI technology leverages the blood vessels as the natural highways to the brain. ...
The ATTUNE AFFIXIUM Knee is the first in the ATTUNE Knee portfolio to utilize this advanced 3D printing technology, which creates a three-dimensional lattice structure, generating a similar porosity to natural bone for advanced biological fixationxv and helps enhance initial implant stability.xvi “The ATTUNE AFFIXIUM Knee is a game changer for ...
Synchron is the only company to receive FDA approval to conduct clinical trials of a permanently implanted BCI. The company’s novel BCI technology leverages the blood vessels as the natural highways to the brain. ...
“The PA5108 Ocular Implant with Prezia Sustained Drug Delivery Technology may provide a significant advancement in the treatment of glaucoma with the laudable goal of enabling a constant dose of medication for six months via a safe and effective biodegradable ...
Chris joins the Hyalex team with an impressive background in leading numerous clinical trials of implanted medical devices and taking innovative technologies through US PMA and international regulatory approvals. ...
“So far, our combination technology has, in preclinical studies, demonstrated its ability to resolve existing metastatic bone lesions, inhibit pain and stimulate targeted bone regeneration. ...
” About the Stentrode Synchron’s flagship technology, the Stentrode is an endovascular brain implant designed to enable patients to wirelessly control digital devices through thought and improve functional independence. Synchron’s foundational technology, a motor neuroprosthesis (MNP), is implanted via the ...
Food and Drug Administration (FDA) for its ZetaMet™ technology. Previously known as ZetaFuse™, ZetaMet™ is a synthetic, small-molecule, inductive biologic technology being developed to target and resolve metastatic bone lesions while inhibiting future tumor growth and regenerating bone. ...
Grebner joins the Biorez team at an opportune time as the company hits key clinical and procedural milestones with its proprietary BioBrace Implant technology in 2021. “Jeff is a thoughtful clinical leader with extensive relationships and experience managing end-to-end pre and post-market evidence generation initiatives from concept through completion and ...